Pfizer Inc. buy Guggenheim
Start price
23.02.24
/
50%
€25.55
Target price
23.02.25
€33.22
Performance (%)
4.76%
Price
17:54
€25.99
Summary
This prediction is currently active. With a performance of 4.76%, the BUY prediction by Guggenheim for Pfizer Inc. is trending in the right direction. A total of €0.78 was paid as dividends for this prediction. This prediction currently runs until 23.02.25. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Pfizer Inc. | -0.656% | -0.656% |
iShares Core DAX® | -1.471% | 1.895% |
iShares Nasdaq 100 | -0.486% | 4.395% |
iShares Nikkei 225® | -2.115% | 2.450% |
iShares S&P 500 | 0.394% | 3.118% |
Comments by Guggenheim for this prediction
In the thread Pfizer Inc. diskutieren
Pfizer Inc. (NYSE: PFE) is now covered by analysts at Guggenheim. They set a "buy" rating and a $36.00 price target on the stock.
Ratings data for PFE provided by MarketBeat